Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05443906 · ClinicalTrials.gov registry record · NA

Home Exercise for Individuals with Neurodegenerative Disease

A NA study of Neurodegenerative Diseases and Cerebellar Ataxia, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05443906 is a NA study of Neurodegenerative Diseases and Cerebellar Ataxia that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 30 participants, below the 168,532-participant average among 12 other Neurodegenerative Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05443906, a NA study of Neurodegenerative Diseases and Cerebellar Ataxia, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Interventions

  • BEHAVIORAL Home exercise

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-02-13
Est. Completion 2027-07-30
Phase NA

What the Registry Record Tells You About NCT05443906

The ClinicalTrials.gov registry entry for NCT05443906 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168,532-participant average among 12 other Neurodegenerative Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Neurodegenerative Diseases appearing as the primary indexed condition, and to 1 intervention - of which Home exercise is the first listed.

NCT05443906 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05443906 about?

NCT05443906 is a clinical study titled "Home Exercise for Individuals with Neurodegenerative Disease". The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

What is the current status of trial NCT05443906?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-02-13. Estimated completion is 2027-07-30.

What conditions does trial NCT05443906 study?

This clinical trial studies the following conditions: Neurodegenerative Diseases, Cerebellar Ataxia, Ataxia, Leukodystrophy, LBSL.

What interventions are being tested in trial NCT05443906?

The interventions under investigation include: Home exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05443906?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05443906 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neurodegenerative Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.